Missouri reports rare Naegleria fowleri brain-eating amoeba infection possibly linked to water skiing
Naegleria fowleri
brain-eating amoeba infection, possibly contracted after water skiing in the
Lake of the Ozarks
, the Missouri Department of Health and Senior Services said Wednesday, August 13.
The patient, whose identity has not been released, is receiving treatment in an intensive care unit. Health officials said the illness developed days after the patient visited the lake. The source of exposure is still under investigation.
Finance
Value and Valuation Masterclass - Batch 4
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals Batch 2
By Ansh Mehra
View Program
Finance
Value and Valuation Masterclass - Batch 3
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals
By Vaibhav Sisinity
View Program
Finance
Value and Valuation Masterclass - Batch 2
By CA Himanshu Jain
View Program
Finance
Value and Valuation Masterclass Batch-1
By CA Himanshu Jain
View Program
Also read:
Deadly brain-eating amoeba kills Texas woman: how to be safe?
The Lake of the Ozarks State Park has two public beaches, according to its website, though officials did not specify which location the patient visited. Naegleria fowleri is a microscopic amoeba found in warm freshwater. The infection it causes, primary amebic meningoencephalitis (PAM), is rare but severe. The organism can enter the brain when water is forced up the nose during activities such as swimming, diving, or water skiing, according to the Centers for Disease Control and Prevention (CDC).
From 1962 to 2024, there have been 167 reported PAM cases in the United States, the Missouri health department said.
Live Events
Last month, 12-year-old Jaysen Carr of South Carolina died after contracting the amoeba. It was the state's first known case since 2016, according to the South Carolina Department of Public Health. His family has spoken publicly, urging awareness to prevent similar cases.
The CDC advises precautions to reduce risk, including wearing a nose clip or holding the nose shut when jumping or diving into freshwater and keeping the head above water in hot springs. Early symptoms of infection can include nausea, vomiting, fever, severe headache, stiff neck, seizures, altered mental status, and hallucinations.
The CDC notes that Naegleria fowleri infections cannot be contracted from swallowing contaminated water or through person-to-person transmission.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
3 hours ago
- Hindustan Times
COVID cases on rise in these US states as new variant ‘stratus' spreads. Here's what to know
COVID-19 cases are once again rising across the United States, and health experts believe a new variant, called XFG or 'stratus,' may be to blame. The increase is happening earlier than expected, just before schools reopen, raising fears of more spread in classrooms, Axios reported. The Stratus variant (XFG) of COVID-19 was first detected in January in Southeast Asia,(REUTERS) The variant was first detected in January in Southeast Asia. The World Health Organization had classified it as a 'variant under monitoring' by June, due to its global spread. XFG was given its cloud-themed nickname "Stratus" by evolutionary biologist T. Ryan Gregory. Also read: Trump to meet Putin in Alaska airbase tomorrow: All you need to know about the summit Experts warn of possible summer wave Data from the Centers for Disease Control and Prevention (CDC) shows that 12 states have much higher COVID-19 test positivity rates than the rest of the country. Arizona is among the worst hit, with a positivity rate above 11 per cent. Other states in the southern US, and along the West Coast, are also seeing cases rise or are likely to rise soon. Here is the list of states with the highest COVID test positivity. New Mexico (12%) Texas (12%) Oklahoma (12%) Arkansas (12%) Louisiana (12%) Nevada (11.3%) Arizona (11.3%) California (11.3%) Alaska (11.1%) Washington (11.1%) Oregon (11.1%) Idaho (11.1%) It has been observed that the US faces two distinct waves of COVID, one in the winter and another in the summer, as per USA Today. New variants, peaks in travel and decreasing immunity from prior infection and vaccination can lead to the surge, experts note. Stratus COVID variant: Symptoms The symptoms include sore throat, fatigue, headache, fever or chills, cough, congestion or runny nose, shortness of breath, new loss of sense of taste or smell, muscle aches, and nausea, vomiting or diarrhea. Also read: Prince William once spent a night sleeping on London streets, and here's what happened Stratus COVID variant: How to stay safe? People can take simple steps to be cautious, stay home if unwell and immediately get tested if symptoms appear. Wearing masks in crowded and indoor spaces can help as well, reported. Officials have encouraged people to check the eligibility for updated COVID-19 vaccines or boosters. "Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease," the WHO stated in its June report. For now, the CDC continues to monitor the situation closely, urging Americans to stay informed and take precautions. FAQs Q1. What is the 'stratus' variant? It's a new COVID-19 variant suspected to be driving recent case surges in the US. Q2. Which states are most affected? Arizona and 11 other states have the highest test positivity rates in the country. Q3. What precautions are recommended? Stay home if sick. Get tested if symptoms appear, wear masks in crowded indoor areas, and check eligibility for updated vaccines or boosters.
Time of India
12 hours ago
- Time of India
Apollo Hospitals shares in focus as brokerages hike target prices post strong Q1FY26 results
Apollo Hospitals shares are likely to be in focus on Thursday, August 14, after the company posted a strong set of Q1FY26 results , prompting multiple brokerage firms to raise their target prices for the stock. The healthcare major reported a consolidated net profit of Rs 433 crore for the quarter ended June 30, 2025, marking a 42% year-on-year increase from Rs 305 crore in the same period last year. On a sequential basis, PAT was up 11% from Rs 390 crore in Q4FY25. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Revenue from operations in Q1FY26 rose 15% year-on-year to Rs 5,842 crore compared to Rs 5,086 crore in Q1FY25. Sequentially, revenue grew 4.5% from Rs 5,592 crore in the March quarter. The robust performance was supported by growth across segments, improved specialty mix, and operational efficiency gains. Nuvama: Buy| Target price: Rs 9,010 Nuvama has raised its target price for Apollo Hospitals to Rs 9,010 from Rs 8,635, maintaining a 'Buy' rating. Live Events The brokerage noted strong performance from HealthCo and said sustained execution remains key. It expects hospital growth from H2FY26 through phased bed expansion, higher international patient inflows, and an improved specialty mix. Nuvama also highlighted potential value unlocking from the Keimed merger, front-end restructuring, and a possible listing within 18 months. HealthCo's valuation multiple was raised to 26x from 22x, and FY26E/FY27E EBITDA estimates were increased by 2% and 4%, respectively. Motilal Oswal: Buy| Target price: Rs 9,010 Motilal Oswal also raised its target price to Rs 9,010 from Rs 8,720 while maintaining a 'Buy' rating. The firm cited broad-based growth with EBITDA and PAT beating estimates on cost optimisation and noted that profitability was boosted by lower operating expenses. It highlighted a 14% year-on-year rise in surgical revenues on the back of strong CONGO therapy momentum. HealthCo is on track for cash EBITDA breakeven (excluding ESOP) by Q2FY26/Q3FY26. The brokerage expects 15%, 21%, and 28% CAGR in revenue, EBITDA, and PAT, respectively, over FY25–FY27 and has raised its FY26/FY27 earnings estimates by 7%. Avendus: Buy| Target price: Rs 8,765 Avendus has increased its target price for Apollo Hospitals to Rs 8,765 from Rs 8,515, reiterating a 'Buy' call. The brokerage has advanced the breakeven timeline for the online business EBITDA to FY27 from FY28 earlier. It projects ex-Keimed revenue CAGR at 17% in FY25–FY27, with EBITDA expected at Rs 510 crore and Rs 770 crore for FY26 and FY27, respectively. Offline pharmacy revenue CAGR is also projected at 17%, while existing units' EBITDA CAGR is estimated at 16% in the same period. Avendus factors in the AHCo–Keimed merger in April 2026 and the APL front-end acquisition in April 2027. It expects healthcare services EBITDA CAGR of 14% and AHLL at 22% over FY25–FY27. FY26/FY27 EBITDA estimates have been raised by 4% each, driven by higher AHCo EBITDA, partly offset by new hospital losses. Also read: Zerodha's Nithin Kamath on how a boring, invisible Sebi step brought windfall gains for retail investors ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Time of India
12 hours ago
- Time of India
Dangerous virus on the prowl? Scientists investigate Colorado rabbits with tentacles after alarming mutation fears
Colorado wildlife officials are urging calm after a spate of unusual sightings, rabbits with dark, horn-like growths sprouting from their heads and faces, has stirred public unease and speculation online. While experts say the condition, known as cottontail rabbit papillomavirus (CRPV), is not currently transmissible to humans, some epidemiologists are warning that close monitoring is essential to guard against any future spillover. The disease, spread by biting insects such as mosquitoes and fleas, causes grotesque, wart-like tumors on infected rabbits. In recent days, residents across Northern Colorado have reported seeing the animals in alarming numbers, sometimes with growths obstructing their vision or mouths. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Although CRPV has been documented for decades and is considered largely benign in wild rabbit populations, veterinary virologists note that papillomaviruses have a history of evolving. In rare cases, similar animal viruses have jumped species barriers, raising questions about whether climate change, urban expansion, and surging insect populations could create conditions for mutation. Possible impacts on domestic animals The virus is more dangerous for domesticated rabbits, where it can cause malignant tumors. Pet owners are advised to keep rabbits indoors if infected wildlife are present nearby and to seek veterinary care immediately if symptoms appear. Live Events There is currently no vaccine or treatment for CRPV, either for wild or domestic rabbits. Colorado wildlife officials stress that the public should avoid touching, feeding, or attempting to capture the infected animals. For now, the official message remains clear to keep your distance, protect your pets, and let scientists do their work. FAQs What is the horned rabbit virus ? The horned rabbit virus, formally known as cottontail rabbit papillomavirus (CRPV), is a wildlife disease that causes wart-like or horn-like growths on rabbits' heads and faces. Can the horned rabbit virus infect humans? Currently, there is no evidence that CRPV can infect humans or most household pets. Scientists say it is species-specific, but they continue to monitor for potential mutations. How does the virus spread? CRPV spreads mainly through biting insects such as mosquitoes, fleas, and ticks, making infections more common in warmer months.
